Zhang Wenxuan graduated from the School of Pharmacy at Peking University and has obtained PhD. He is currently a senior researcher and deputy director of the New Drug Development Laboratory at the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. He also serves as a member of the Medicinal Chemistry Professional Committee of the Beijing Pharmaceutical Association, and young editorial board members of the Chinese Journal of Medicinal Chemistry and the Chinese Journal of Antibiotics. He is mainly engaged in the discovery, research and development of preclinical drug candidates for drug-resistant bacterial infections, anti-tumor and treatment of metabolic diseases. He led the discovery of multiple preclinical candidate drugs. He has applied for 4 international patents and over 30 domestic patents (more than 20 have been authorized), and has published over 40 papers in Nat Commun., Acta Pharm Sin B, Eur. J. Med. Chem., etc., He has received multiple project grants from the National Natural Science Foundation and the Beijing Natural Science Foundation.